Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Shire PLC (NASDAQ:SHPG)

174.02
Delayed Data
As of Mar 23
 -0.13 / -0.07%
Today’s Change
161.09
Today|||52-Week Range
209.22
+2.14%
Year-to-Date
Shire (SHPG) Rare Disease Drug Gets Fast Track Designation
Mar 23 / Zacks.com - Paid Partner Content
Shire's (SHPG) Cinryze Label Expanded for Pediatric Use
Mar 16 / Zacks.com - Paid Partner Content
Is Shire Stock a Good Choice for Value Investors Now?
Mar 21 / Zacks.com - Paid Partner Content
Keryx Focuses on Kidney Drug Aurexia Despite Generic Threat
Mar 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close174.15
Today’s open173.71
Day’s range173.56 - 175.40
Volume622,198
Average volume (3 months)1,058,968
Market cap$52.5B
Dividend yield0.52%
Data as of 03/23/2017

Growth & Valuation

Earnings growth (last year)-80.61%
Earnings growth (this year)+14.90%
Earnings growth (next 5 years)+12.30%
Revenue growth (last year)+76.71%
P/E ratio75.3
Price/Sales3.89
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk-0.75-2.21%
REGNRegeneron Pharmaceut...-4.12-1.12%
INCYIncyte Corp-2.31-1.64%
BAXBaxter International...-0.10-0.19%
Data as of 8:19am ET, 03/24/2017

Financials

Next reporting dateMay 2, 2017
EPS forecast (this quarter)$3.47
Annual revenue (last year)$11.3B
Annual profit (last year)$325.1M
Net profit margin5.30%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Executive Director
Jeffrey Poulton
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs